Clarapath Pathology Revenue and Competitors
Estimated Revenue & Valuation
- Clarapath Pathology's estimated annual revenue is currently $6M per year. 0
Employee Data
- 00
Clarapath Pathology's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & Chief Scientific Fellow | Reveal Email/Phone |
2 | Chief Manufacturing, Operations, and Supply Chain Officer | Reveal Email/Phone |
3 | Chief Engineering Fellow | Reveal Email/Phone |
4 | Chief Staff | Reveal Email/Phone |
5 | CEO | Reveal Email/Phone |
6 | Chief Staff | Reveal Email/Phone |
7 | VP Strategy & Corporate Development | Reveal Email/Phone |
8 | Director, Software | Reveal Email/Phone |
9 | Director Engineering and Production | Reveal Email/Phone |
10 | Director, Marketing | Reveal Email/Phone |
Clarapath Pathology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $160M | 800 | 4% | $323.5M | N/A |
#2 | $9.3M | 37 | 12% | N/A | N/A |
#3 | $36.4M | 145 | 2% | N/A | N/A |
#4 | $7M | 28 | 0% | N/A | N/A |
#5 | $1M | 4 | -88% | N/A | N/A |
#6 | $7.5M | 21 | -9% | $6.5M | N/A |
#7 | $6M | 24 | 4% | N/A | N/A |
#8 | $13.1M | 52 | 4% | N/A | N/A |
#9 | $17.1M | 68 | -17% | N/A | N/A |
#10 | $27.9M | 111 | 4% | N/A | N/A |
What Is Clarapath Pathology?
Clarapath is a medical robotics company automating the laboratory. Our first product is focused on fully automating the microtomy station in pathology. Our vision is to innovate, standardize, and digitally transform anatomic pathology through higher quality lab medicine, more robust safety standards, increased lab throughput, while lowering laboratory costs and labor related delays.
keywords:N/AN/A
Total Funding
N/A
Number of Employees
$6M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 2 | 0% | N/A |
#2 | $0.2M | 3 | N/A | N/A |
#3 | $0.4M | 5 | -17% | N/A |
#4 | $0.4M | 5 | -17% | N/A |
#5 | $0.6M | 6 | N/A | N/A |